Article Details

Immunogenicity profiles similar in neovascular AMD for ranibizumab and biosimilar drug

Retrieved on: 2022-10-09 04:26:09

Tags for this article:

Click the tags to see associated articles and topics

Immunogenicity profiles similar in neovascular AMD for ranibizumab and biosimilar drug. View article details on hiswai:

Excerpt

The efficacy data were analyzed based on the patients' antidrug antibody status through week 52, he explained. Antidrug antibody response. The primary ...

Article found on: www.ophthalmologytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up